当前位置：
X-MOL 学术
›
Cancer Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
Cancer Cell ( IF 48.8 ) Pub Date : 2017-06-12 00:00:00 , DOI: 10.1016/j.ccell.2017.05.001 Xiaoju Wang , Yuanyuan Qiao , Irfan A. Asangani , Bushra Ateeq , Anton Poliakov , Marcin Cieślik , Sethuramasundaram Pitchiaya , Balabhadrapatruni V.S.K. Chakravarthi , Xuhong Cao , Xiaojun Jing , Cynthia X. Wang , Ingrid J. Apel , Rui Wang , Jean Ching-Yi Tien , Kristin M. Juckette , Wei Yan , Hui Jiang , Shaomeng Wang , Sooryanarayana Varambally , Arul M. Chinnaiyan
中文翻译：
ERG基因融合产物的拟肽抑制剂在前列腺癌中的发展。
更新日期：2017-06-13
Cancer Cell ( IF 48.8 ) Pub Date : 2017-06-12 00:00:00 , DOI: 10.1016/j.ccell.2017.05.001 Xiaoju Wang , Yuanyuan Qiao , Irfan A. Asangani , Bushra Ateeq , Anton Poliakov , Marcin Cieślik , Sethuramasundaram Pitchiaya , Balabhadrapatruni V.S.K. Chakravarthi , Xuhong Cao , Xiaojun Jing , Cynthia X. Wang , Ingrid J. Apel , Rui Wang , Jean Ching-Yi Tien , Kristin M. Juckette , Wei Yan , Hui Jiang , Shaomeng Wang , Sooryanarayana Varambally , Arul M. Chinnaiyan
|
(Cancer Cell 31, 532–548; April 10, 2017)
中文翻译：
ERG基因融合产物的拟肽抑制剂在前列腺癌中的发展。
（癌细胞31，532-548; 2017年4月10日）
京公网安备 11010802027423号